DHR 📈 Danaher - Overview

Danaher Corporation is a global leader in the design, manufacture, and marketing of a wide range of professional, medical, industrial, and commercial products and services. With a diverse portfolio, the company operates across multiple segments, including Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment, for instance, offers an array of bioprocess technologies, consumables, and services that cater to the development and manufacture of therapeutics, including cell line and cell culture media development services, cell culture media, process liquids, and buffers for manufacturing, as well as chromatography resins, filtration technologies, and aseptic fill finish solutions.

The Life Sciences segment is another key area of focus for Danaher, providing a broad range of products and services, including mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization. This segment also encompasses microscopes, protein consumables, industrial filtration products, and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins, all of which are offered under a portfolio of well-established brands, including ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX.

In the Diagnostics segment, Danaher offers a comprehensive suite of products and services, including chemistry, immunoassay, microbiology, and automation systems, as well as molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings, underscoring the company's commitment to supporting the delivery of high-quality patient care. Furthermore, Danaher has established research collaborations with prestigious institutions, such as Stanford University's Department of Bioengineering, to advance cancer drug development and other critical areas of medical research.

With a history dating back to 1969, Danaher Corporation has evolved significantly over the years, having changed its name from Diversified Mortgage Investors, Inc. to Danaher Corporation in 1984. Today, the company is headquartered in Washington, the District of Columbia, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol DHR. As a common stock, Danaher is classified under the GICS Sub Industry of Health Care Equipment, reflecting its core focus on developing and delivering innovative healthcare solutions. For more information, investors and stakeholders can visit the company's website at https://www.danaher.com, with the company's ISIN identified as US2358511028.